resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
d941428a-ebcb-4acf-90ae-107d7cfc52d1,MCRIi020-A,['Cell Line'],"The MCRIi020-A cell line, also known as NF1_043.7, is an induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) of a 7-year-old female Caucasian patient with Neurofibromatosis Type 1.","['Cell line origin', 'Patient demographics']",,,,https://doi.org/10.1016/j.scr.2020.102013
d941428a-ebcb-4acf-90ae-107d7cfc52d1,MCRIi020-A,['Cell Line'],"The MCRIi020-A cell line exhibited normal morphology, expressed pluripotency markers Oct4 and Nanog, and showed high expression levels of TRA-1-81 (>91%), SSEA4 (>84%), and CD9 (>98%) in flow cytometry analysis, confirming its pluripotent stem cell characteristics.","['Pluripotency', 'Cell line characterization']",,,,https://doi.org/10.1016/j.scr.2020.102013
d941428a-ebcb-4acf-90ae-107d7cfc52d1,MCRIi020-A,['Cell Line'],"The MCRIi020-A cell line was derived through reprogramming using Sendai virus vectors, resulting in a clonal induced pluripotent stem cell line.",['Cell line derivation method'],,,,https://doi.org/10.1016/j.scr.2020.102013
d941428a-ebcb-4acf-90ae-107d7cfc52d1,MCRIi020-A,['Cell Line'],"The MCRIi020-A cell line was established along with three other non-isogenic Neurofibromatosis Type 1 patient-derived iPSC lines (MCRIi021-A, MCRIi022-A, MCRIi023-A) as part of a multi-line study.",['Study design'],,,,https://doi.org/10.1016/j.scr.2020.102013
